SU548275A1 - The method of obtaining hyperimmune anti-purulent antitoxic human plasma - Google Patents

The method of obtaining hyperimmune anti-purulent antitoxic human plasma

Info

Publication number
SU548275A1
SU548275A1 SU2339302A SU2339302A SU548275A1 SU 548275 A1 SU548275 A1 SU 548275A1 SU 2339302 A SU2339302 A SU 2339302A SU 2339302 A SU2339302 A SU 2339302A SU 548275 A1 SU548275 A1 SU 548275A1
Authority
SU
USSR - Soviet Union
Prior art keywords
human plasma
antitoxic
purulent
hyperimmune anti
obtaining
Prior art date
Application number
SU2339302A
Other languages
Russian (ru)
Inventor
Семен Владимирович Скуркович
Марина Антоновна Крохина
Гюльнара Музафаровна Даватдарова
Галина Петровна Черкас
Людмила Григорьевна Подгорная
Анна Афанасьевна Шинкаренко
Original Assignee
Центральный Ордена Ленина Научно-Исследовательский Институт Гематологии И Переливания Крови
Харьковский Научно-Исследовательский Институт Микробиологии,Вакцин И Сывороток Им.И.И.Мечникова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Центральный Ордена Ленина Научно-Исследовательский Институт Гематологии И Переливания Крови, Харьковский Научно-Исследовательский Институт Микробиологии,Вакцин И Сывороток Им.И.И.Мечникова filed Critical Центральный Ордена Ленина Научно-Исследовательский Институт Гематологии И Переливания Крови
Priority to SU2339302A priority Critical patent/SU548275A1/en
Application granted granted Critical
Publication of SU548275A1 publication Critical patent/SU548275A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Description

(54) СПОСОБ ПОЛУЧЕНИЯ ГИПЕРИММУННОЙ АНТИСИНЕГНОЙНОЙ АНТИТОКСИЧЕСКОЙ ЧЕЛОВЕЧЕСКОЙ(54) METHOD FOR OBTAINING A HYPERIMMUNIC ANTISINEGIC ANTITOXIC HUMAN

ПЛАЗМЫPLASMA

Препарат обла/чает высокой лечебной эффективностью при различных заболевани х, вызванных синегнойной палочкой (послеоперационный сепсис, пиелонефрит, посттравматический остеомиелит, ожоговый сепсис, осложнени  открытых переломов).The drug has a high curative efficacy in various diseases caused by the pyocyanic stick (postoperative sepsis, pyelonephritis, post-traumatic osteomyelitis, burn sepsis, complications of open fractures).

Гипериммунную антисинегнойную антитоксическую человеческую плазму ввод т больным внутривенно из расчета 3-5 мл на 1 кг веса ежедневно или через день 3-6 раз в зависимости от т жести клинического течени  патологического процесса.Hyperimmune antiseptic anti-toxic human plasma is administered intravenously to patients at the rate of 3-5 ml per 1 kg of body weight daily or every other day 3-6 times depending on the severity of the clinical course of the pathological process.

Claims (1)

. Формула изобретени . Invention Formula Способ получени  гипериммунной антисинегнойной антитоксической человеческой плазмы , отличающийс  тем, что доноров трекратно иммунизируют анатоксином синегнойной палочки подкожно в дозе 1,0-1,0-1,5 мл, извлекают иммунную плазму и лиофильно высушивают.A method for producing a hyperimmune antiseptic pest anti-toxic human plasma, characterized in that the donors are immunized three times with a toxoid of the syrup pylorus subcutaneously at a dose of 1.0-1.0-1.5 ml, the immune plasma is extracted and lyophilized.
SU2339302A 1976-03-31 1976-03-31 The method of obtaining hyperimmune anti-purulent antitoxic human plasma SU548275A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU2339302A SU548275A1 (en) 1976-03-31 1976-03-31 The method of obtaining hyperimmune anti-purulent antitoxic human plasma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU2339302A SU548275A1 (en) 1976-03-31 1976-03-31 The method of obtaining hyperimmune anti-purulent antitoxic human plasma

Publications (1)

Publication Number Publication Date
SU548275A1 true SU548275A1 (en) 1977-02-28

Family

ID=20653954

Family Applications (1)

Application Number Title Priority Date Filing Date
SU2339302A SU548275A1 (en) 1976-03-31 1976-03-31 The method of obtaining hyperimmune anti-purulent antitoxic human plasma

Country Status (1)

Country Link
SU (1) SU548275A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11634257B2 (en) 2017-10-09 2023-04-25 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11634257B2 (en) 2017-10-09 2023-04-25 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11609043B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
US11609042B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
US11740019B2 (en) 2019-03-14 2023-08-29 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11747082B2 (en) 2019-03-14 2023-09-05 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
US11815311B2 (en) 2019-03-14 2023-11-14 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
US11994343B2 (en) 2019-03-14 2024-05-28 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use

Similar Documents

Publication Publication Date Title
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
RU96101193A (en) ANTIBODY FRAGMENTS IN THERAPY
DE69418601T2 (en) GUANID DERIVATIVES WITH THERAPEUTIC EFFECT
RU92016463A (en) APPLICATION OF DERIVATIVES OF TISSTINES FOR THE MANUFACTURE OF MEDICINES WITH IMMUNOMODING EFFECT, PHARMACEUTICAL COMPOSITIONS ON THEIR BASIS
GB1499035A (en) Antistaphylococcus human immune globulin and method of preparing same
SU548275A1 (en) The method of obtaining hyperimmune anti-purulent antitoxic human plasma
RU93042874A (en) POLYPEPTIDE NATURE COMPOUNDS, METHOD FOR THEIR PRODUCTION, A COMPOSITION ON THEIR BASIS, THEIR APPLICATION IN ANTI-CANCER THERAPY
ES2044848T3 (en) USE OF PETASITE EXTRACTS TO PREPARE A MEDICATION FOR THE TREATMENT OF GASTROINTESTINAL DISEASES.
Bloom et al. Clinical evaluation of prazosin as the sole agent for the treatment of hypertension: A double-blind cross-over study with methyldopa.
Merritt Corticotropin and cortisone in diseases of the nervous system
KR960700711A (en) Medicine for treating or preventing cerebrovascular diseases
SU1105202A1 (en) Method of treatment of gastric ulcer and duodenal ulcer
IE853206L (en) Use of aminosulfonic acids in treatment of inflammatory¹conditions
Mwetta et al. Community treatment with ivermectin for onchocerciasis in the east Usambara mountains
SU1261665A1 (en) Method of treatment of thymomegalia of children
SU1169655A1 (en) Method of treatment of thrombolytic diseases of the artery of the extremities
RU2166960C2 (en) Method for preventing early stage sepsis in children having severe burns
SU1337101A1 (en) Method of treatment of erysipelatous inflammation
RU2120292C1 (en) Method for treating cerebrovascular crisis
KR920021152A (en) Anti-neurotoxic activity of the methyl ester of GM_VII ganglioside and its therapeutic use
Yatskov Neurological characteristic of the diseases caused by venomous medusa Gonionemus vertens vertens).
Bell 3. The Treatment of Amoebic Dysentery
RU2003344C1 (en) Method for burn disease treatment
SU1136798A1 (en) Method of treatment of hyperactive behavour
RU93044773A (en) METHOD FOR TREATING DISORDERS OF THE MENSTRUAL CYCLE